Key terms
About TNYA
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TNYA news
Apr 05
6:56am ET
Tenaya Therapeutics’ Strategic Advantages in Cardiovascular Genetic Medicine Garner Buy Rating
Mar 28
7:05am ET
Optimistic Buy Rating for Tenaya Therapeutics Based on Promising Gene Therapy Pipeline and Upcoming Clinical Milestones
Mar 21
8:50am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vera Therapeutics (VERA), Tyra Bioscience (TYRA) and Tenaya Therapeutics (TNYA)
Mar 21
2:17am ET
Buy Rating Affirmed for Tenaya Therapeutics: A Combination of Solid Financials and Promising Clinical Pipeline
Mar 21
12:20am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 21
12:10am ET
Analysts Offer Insights on Healthcare Companies: Sera Prognostics (SERA) and Tenaya Therapeutics (TNYA)
Mar 21
12:00am ET
Analysts Offer Insights on Healthcare Companies: Sera Prognostics (SERA) and Tenaya Therapeutics (TNYA)
Mar 20
11:50pm ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 20
11:40pm ET
Analysts Are Bullish on These Healthcare Stocks: Tenaya Therapeutics (TNYA), Telix Pharmaceuticals Ltd. (TLPPF)
Mar 20
11:30pm ET
Analysts Offer Insights on Healthcare Companies: Sera Prognostics (SERA) and Tenaya Therapeutics (TNYA)
Mar 20
11:20pm ET
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA) and Sera Prognostics (SERA)
Mar 20
11:10pm ET
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA) and Sera Prognostics (SERA)
Mar 20
11:00pm ET
Analysts Are Bullish on Top Healthcare Stocks: Sera Prognostics (SERA), Tenaya Therapeutics (TNYA)
Mar 20
10:50pm ET
Analysts Offer Insights on Healthcare Companies: Sera Prognostics (SERA) and Tenaya Therapeutics (TNYA)
Mar 20
10:40pm ET
Analysts Are Bullish on These Healthcare Stocks: Sera Prognostics (SERA), Tenaya Therapeutics (TNYA)
Mar 20
10:30pm ET
Analysts Are Bullish on Top Healthcare Stocks: Tenaya Therapeutics (TNYA), Sera Prognostics (SERA)
Mar 20
7:05am ET
Tenaya Therapeutics price target lowered to $18 from $19 at Canaccord
Mar 20
2:00am ET
Tenaya Therapeutics’ Financial Tightrope: Balancing Development Costs with Cash Reserves
Mar 19
6:40am ET
Analysts’ Top Healthcare Picks: Inventiva (IVA), Tenaya Therapeutics (TNYA)
Mar 19
6:25am ET
Buy Rating Justified by Tenaya Therapeutics’ Strong Financials and Promising Cardiovascular Pipeline Progress
Mar 18
11:55pm ET
TD Cowen Keeps Their Buy Rating on Tenaya Therapeutics (TNYA)
Mar 18
4:11pm ET
Tenaya Therapeutics reports Q4 EPS (40c), consensus (44c)
Mar 18
8:35am ET
Tenaya announces publication of TN-401 gene therapy preclinical data
Feb 26
8:38am ET
Tenaya Therapeutics announces publication of preclinical HDAC6 inhibitor data
Feb 13
6:00am ET
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Dexcom (DXCM) and Tenaya Therapeutics (TNYA)
Feb 09
4:17am ET
Tenaya Therapeutics Announces Speculative Offering Outlook
Feb 09
4:17am ET
Tenaya Therapeutics Secures $50 Million in Share Sale
Feb 08
8:17am ET
Tenaya Therapeutics prices 8.89M shares at $4.50 in underwritten offering
Feb 08
8:15am ET
Tenaya Therapeutics 8.888M share Secondary priced at $4.50
No recent press releases are available for TNYA
TNYA Financials
Key terms
Ad Feedback
TNYA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TNYA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range